Citation Impact
Citing Papers
DiarrheagenicEscherichia coli
1998 Standout
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
2018 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom.
2004
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice
2020 StandoutNobel
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Increased Fidelity Reduces Poliovirus Fitness and Virulence under Selective Pressure in Mice
2005
Experimental models of inflammatory bowel disease
1995 Standout
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
2010 Standout
Granulocyte-Macrophage Colony-Stimulating Factor as Immunomodulating Factor Together with Influenza Vaccination in Stem Cell Transplant Patients
2000
Geographic distribution of wild poliovirus type 1 genotypes
1987
Role of acute infection in triggering acute coronary syndromes
2010
Viral diversity and dynamics in an infant gut
2008
Influenza Infection and Risk of Acute Myocardial Infarction in England and Wales: A CALIBER Self-Controlled Case Series Study
2012
Viral agents of acute gastroenteritis in German children: Prevalence and molecular diversity
2003
Prevention and Treatment of Traveler's Diarrhea
1993
Viruses in the faecal microbiota of monozygotic twins and their mothers
2010 StandoutNature
The Diagnosis and Management of Acute Otitis Media
2013 Standout
Crohn's disease
2012 Standout
Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants
1996
B Cells and Transplantation: An Educational Resource
2009
Diagnosis and Treatment of Acute or Persistent Diarrhea
2009
Clinical Features and Duration of Traveler's Diarrhea in Relation to Its Etiology
1994
The Nucleotide Sequence of Coxsackievirus A9; Implications for Receptor Binding and Enterovirus Classification
1989
Infectious agents and atherosclerotic vascular disease
1996
Bacterial Lipopolysaccharide Binding Enhances Virion Stability and Promotes Environmental Fitness of an Enteric Virus
2014
Complications of RNA Heterogeneity for the Engineering of Virus Vaccines and Antiviral Agents
1992
Population Bottlenecks in Quasispecies Dynamics
2006
First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: A proof of concept for the wastewater surveillance of COVID-19 in the community
2020 Standout
AETIOLOGICAL ASSOCIATION OF A VIRUS-LIKE PARTICLE WITH ENTERICALLY TRANSMITTED NON-A, NON-B HEPATITIS
1988
Hepatitis E virus (HEV): Molecular cloning and sequencing of the full-length viral genome
1991 Standout
New observations on antigenic diversification of RNA viruses. Antigenic variation is not dependent on immune selection
1993
Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review
2009
DIFFERENTIAL IMMUNE RESPONSE TO INFLUENZA AND PNEUMOCOCCAL VACCINATION IN IMMUNOSUPPRESSED PATIENTS AFTER HEART TRANSPLANTATION
1998
Graft-versus-host disease
2009 Standout
The Impact of the Gut Microbiota on Human Health: An Integrative View
2012 Standout
Neutralizing antiviral antibody responses
2001
C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease
2004 Standout
High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease
2004 Standout
Vaccines for Transplant Recipients
2001
Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213
1995 StandoutNobel
Role of environmental poliovirus surveillance in global polio eradication and beyond
2011
Antibiotic resistance in the environment
2021 Standout
Mice carrying a knock-in mutation of Aicda resulting in a defect in somatic hypermutation have impaired gut homeostasis and compromised mucosal defense
2011 StandoutNobel
Enteric viruses in the aquatic environment
2001
Spectrum of Disease and Relation to Place of Exposure among Ill Returned Travelers
2006 Standout
Antibody Titers and Immune Response to Diphtheria-Tetanus-Pertussis and Measles-Mumps-Rubella Vaccination in Children Treated for Acute Lymphoblastic Leukemia
2005
Emerging pollutants in the environment: present and future challenges in biomonitoring, ecological risks and bioremediation
2014
Travellers' diarrhoea
1993
Maternal antibodies and infant immune responses to vaccines
2015
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT
2005
Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media
2001 Standout
Epidemiology of the Guillain-Barré syndrome
2001
Presence of specific viruses in the middle ear fluids and respiratory secretions of young children with acute otitis media
2003
Epidemiology, Etiology and Pathophysiology of Traveler’s Diarrhea
2006
Travellers' diarrhoea
2003
Comparative Value of Colonic Biopsy and Intraluminal Fluid Culture for Diagnosis of Bacterial Acute Colitis in Immunocompetent Patients
1999
Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease
2002 Standout
A Single Mutation in Chikungunya Virus Affects Vector Specificity and Epidemic Potential
2007 Standout
Guillain-Barré syndrome
2005 Standout
IgG Subclasses and Allotypes: From Structure to Effector Functions
2014 Standout
Humoral immunity to viral and bacterial antigens in lymphoma patients 4–10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines
2001
Prevalence of Enteric Pathogens among International Travelers with Diarrhea Acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay)
2002
Climate change and human health: present and future risks
2006 Standout
SARS-CoV-2 in wastewater: State of the knowledge and research needs
2020 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Respiratory Viruses, Symptoms, and Inflammatory Markers in Acute Exacerbations and Stable Chronic Obstructive Pulmonary Disease
2001
RNA virus evolution and the control of viral disease
1989
High Variety of Known and New RNA and DNA Viruses of Diverse Origins in Untreated Sewage
2012
Foot-and-Mouth Disease
2004 Standout
Impaired Gamma Interferon Responses against Parvovirus B19 by Recently Infected Children
2000
Prolonged faecal excretion of poliovirus in a nurse with common variable hypogammaglobulinaemia
1991
Human Parvovirus B19
2002 Standout
Detection of Pathogenic Viruses in Sewage Provided Early Warnings of Hepatitis A Virus and Norovirus Outbreaks
2014
Fly Transmission ofCampylobacter
2005
Rotavirus and Severe Childhood Diarrhea
2006 Standout
Unmutated Immunoglobulin M Can Protect Mice from Death by Influenza Virus Infection
2003 StandoutNobel
Enterotoxigenic Escherichia coli in Developing Countries: Epidemiology, Microbiology, Clinical Features, Treatment, and Prevention
2005 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
Roles of Infectious Agents in Atherosclerosis and Restenosis
1997 Standout
Emerging investigators series: sewer surveillance for monitoring antibiotic use and prevalence of antibiotic resistance: urban sewer epidemiology
2016
Infections, Inflammation, and the Risk of Coronary Heart Disease
2000
Inflammation and Atherosclerosis
2002 Standout
Assessment of an Enterovirus Sewage SurveillanceSystem by Comparison of Clinical Isolates with Sewage Isolatesfrom Milwaukee, Wisconsin, Collected August 1994 toDecember2002
2003
Global Epidemiology of Campylobacter Infection
2015 Standout
The clinical significance of immunoglobulin A deficiency
2007
Immunity to Campylobacter: its role in risk assessment and epidemiology
2009
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
The GenusAeromonas: Taxonomy, Pathogenicity, and Infection
2010 Standout
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Hafnia alvei in stool specimens from patients with diarrhea and healthy controls
1994
Safety and Immunogenicity of a Prototype EnterotoxigenicEscherichia coliVaccine Administered Transcutaneously
2002
Viral and bacterial infections in patients with acute myocardial infarction
1989
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
Ontogeny of the Mucosal Immune System and IgA Deficiency
1991
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Oral Aztreonam, A Poorly Absorbed Yet Effective Therapy for Bacterial Diarrhea in US Travelers to Mexico
1992
Abdominal Aortic Aneurysm
2006 Standout
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms
1996
Insights into the regulatory mechanism controlling the inhibition of vaccine-induced seroconversion by maternal antibodies
2011
Single Dose Ofloxacin plus Loperamide Compared with Single Dose or Three Days of Ofloxacin in the Treatment of Traveler's Diarrhea
1997
Enteric bacteria promote human and mouse norovirus infection of B cells
2014 StandoutScience
Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation
2006
C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men
1999 Standout
Works of Mirja Stenvik being referenced
Poliovirus surveillance by examining sewage specimens. Quantitative recovery of virus after introduction into sewerage at remote upstream location
2001
Simultaneous administration of Haemophilus influenzae type b capsular polysaccharide-diphtheria toxoid conjugate vaccine with routine diphtheria-tetanus-pertussis and inactivated poliovirus vaccinations of childhood
1988
Nucleic acid sequence relationships between enterovirus serotypes
1987
Inadequacy of musocal IgM antibodies in selective IgA deficiency: Excretion of attenuated polio viruses is prolonged
1988
A population-based prospective survey of newborn infants with suspected systemic infection: occurrence of sporadic enterovirus and adenovirus infections
1999
Seasonal Variation in Etiology of Travelers' Diarrhea
1992
Age- and dose-interval-dependent antibody responses to inactivated poliovirus vaccine
2001
Environmental surveillance of wild poliovirus circulation in Egypt—Balancing between detection sensitivity and workload
2005
Randomized comparison of early and late vaccination with inactivated poliovirus vaccine after allogeneic BMT
1997
Loss of protective immunity to polio, diphtheria andHaemophilus influenzaetype b after allogeneic bone marrow transplantation
1996
Efficacy of PCR and other diagnostic methods for the detection of respiratory adenoviral infections
1999
Viruses in sewage waters during and after a poliomyelitis outbreak and subsequent nationwide oral poliovirus vaccination campaign in Finland
1988
Coxsackie B Virus Antibodies in Myocardial Infarction
1983
Viral and mycoplasmal antibodies in patients with myocardial infarction.
1981
Evolution of wild-type 1 poliovirus in two healthy siblings excreting the virus over a period of 6 months
2004
Surveillance of patients with acute flaccid paralysis in Finland: report of a pilot study.
2000
Proportions of immunoglobulin isotypes in paralytic poliomyelitis and after vaccination
1987
Antigenic and Molecular Properties of Type 3 Poliovirus Responsible for an Outbreak of Poliomyelitis in a Vaccinated Population
1986
Outbreak of Poliomyelitis in Finland in 1984: Description of Nine Cases with Persisting Paralysis
1986
OUTBREAK OF PARALYTIC POLIOMYELITIS IN FINLAND: WIDESPREAD CIRCULATION OF ANTIGENICALLY ALTERED POLIOVIRUS TYPE 3 IN A VACCINATED POPULATION
1986